×
Metastatic Urothelial Cancer: A Conversation on State-of-the-Art Treatment Before the ASCO20 Virtual Scientific Program
https://ascopost.com/videos/asco20-virtual-scientific-program/metastatic-urothelial-cancer-a-conversation-before-the-asco20-virtual-scientific-program/

May 25th, 2020 - As Thomas Powles, MD, PhD, of Queen Mary University of London, prepares to deliver his late-breaking presentation at the ASCO20 Virtual Scientific Program (LBA-1), he talks with Christopher Sweeney, MBBS, of Dana-Farber Cancer Institute, about current therapy: PD1/PDL1 inhibition in second-line treatment and as monotherapy in the first-line setting, as well as the concept of maintenance switch.

New OS data with olaparib support ‘new era’ for ovarian cancer
https://www.mdedge.com/hematology-oncology/article/222254/gynecologic-cancer/new-os-data-olaparib-support-new-era-ovarian

May 13th, 2020 - Women with platinum-sensitive relapsed ovarian cancer and a BRCA mutation could see their survival extended by over a year by maintenance therapy with the PARP-inihibitor olaparib (Lynparza, AstraZeneca).

Geriatric assessment and management improves quality of life for older adults with cancer
https://www.healio.com/hematology-oncology/geriatric-oncology/news/online/{647dd8b3-cfe6-481b-9583-5899606bac98}/geriatric-assessment-and-management-improves-quality-of-life-for-older-adults-with-cancer

May 13th, 2020 - Use of comprehensive geriatric assessment and integration of geriatrician-led management into care plans improved health-related quality of life for older adults receiving systemic anticancer therapy, according to results of the prospective, randomized INTEGERATE trial scheduled for presentation during the ASCO20 Virtual Scientific Program.

Quitting smoking just 2 years before lung cancer diagnosis may improve survival
https://www.mdedge.com/hematology-oncology/article/222276/lung-cancer/quitting-smoking-just-2-years-lung-cancer-diagnosis

May 13th, 2020 - Quitting smoking prior to a lung cancer diagnosis is associated with a survival benefit, even among patients who recently stopped smoking, according to results of a pooled analysis.

Medicaid expansion states see bigger declines in cancer mortality rates
https://www.healio.com/hematology-oncology/cancer-prevention/news/online/{2df2af75-c18b-4f1f-a53b-32c30b2b7c5e}/medicaid-expansion-states-see-bigger-declines-in-cancer-mortality-rates

May 13th, 2020 - States that expanded Medicaid under the Affordable Care Act witnessed significant declines in cancer mortality rates compared with states that did not expand Medicaid, according to study results scheduled for presentation during the ASCO20 Virtual Scientific Program.

ASCO Preview: Boosting Survival in Ovarian Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86486

May 13th, 2020 - Women with relapsed, platinum-sensitive ovarian cancer associated with BRCA mutations lived more than a year longer if they received olaparib (Lynparza) following chemotherapy, data from a randomized trial showed.

Video coaching may relieve anxiety and distress for long-distance cancer caregivers
https://www.mdedge.com/hematology-oncology/article/222241/patient-survivor-care/video-coaching-may-relieve-anxiety-and

May 13th, 2020 - Anxiety and distress related to caring for a cancer patient who lives far away may be alleviated through an intervention that includes video-based coaching sessions with a nurse practitioner or social worker, a randomized study suggests.

Smoking cessation before lung cancer diagnosis linked to longer survival
https://www.healio.com/hematology-oncology/lung-cancer/news/online/{c987a307-b1e1-44ae-aae8-0d53228ea219}/smoking-cessation-before-lung-cancer-diagnosis-linked-to-longer-survival

May 12th, 2020 - People who quit smoking prior to a lung cancer diagnosis demonstrated considerably reduced risk for death due to all causes compared with those who continued to smoke, according to study results scheduled for presentation during the ASCO20 Virtual Scientific Program.

Maintenance olaparib extends OS among women with BRCA-mutated relapsed ovarian cancer
https://www.healio.com/hematology-oncology/gynecologic-cancer/news/online/{52c91a81-35d2-44a5-bf2c-79e8db377b40}/maintenance-olaparib-extends-os-among-women-with-brca--mutated-relapsed-ovarian-cancer

May 12th, 2020 - Maintenance therapy with olaparib extended OS compared with placebo among women with platinum-sensitive, BRCA-mutated relapsed ovarian cancer, according to the final analysis of the randomized phase 3 SOLO-2 study scheduled for presentation during the ASCO20 Virtual Scientific Program.

ASCO Preview: Cancer Deaths Down in Medicaid Expansion States
https://www.medpagetoday.com/meetingcoverage/asco/86480

May 12th, 2020 - Medicaid expansion under the Affordable Care Act (ACA) was associated with reduced mortality rates among cancer patients, a large retrospective analysis found.

Maintenance Olaparib Provides Significant Long-Term OS Benefit in Relapsed Ovarian Cancer
https://www.targetedonc.com/view/maintenance-olaparib-provides-significant-long-term-os-benefit-in-relapsed-ovarian-cancer

May 12th, 2020 - Maintenance treatment with olaparib (Lynparza) demonstrated an improved median overall survival (OS) of 12.9 months over placebo in patients with platinum-sensitive relapsed ovarian cancer harboring a BRCA1/2 mutation, according to final OS results from the phase III SOLO2/ENGOT-ov21 trial.

Cancer Mortality Rate Declined More Steeply in States That Expanded Medicaid Under the Affordable Care Act
https://www.onclive.com/conference-coverage/asco-2020/cancer-mortality-rate-declined-more-steeply-in-states-that-expanded-medicaid-under-the-affordable-care-act

May 12th, 2020 - The cancer mortality rate declined more in states that expanded Medicaid coverage than those that didn’t follow the passage of the Affordable Care Act (ACA) of 2010, a study found. The data were presented during a press cast in advance of the 2020 American Society of Clinical Oncology (ASCO) Meeting, set for May 29-31. Researchers will present their findings during the meeting’s virtual scienti...

Maintenance Therapy with Olaparib Extends Survival in Relapsed, BRCA+ Ovarian Cancer
https://www.onclive.com/conference-coverage/asco-2020/maintenance-therapy-with-olaparib-extends-survival-in-relapsed-embrcaem-ovarian-cancer

May 12th, 2020 - Treatment with olaparib (Lynparza) in the maintenance setting extended overall survival (OS) by 12.9 months in women with platinum-sensitive relapsed ovarian cancer with BRCA1/2 mutations, compared with placebo, according to randomized phase 3 trial results presented during a 2020 ASCO Virtual Scientific Program press briefing.

Regardless of Timing, Smoking Cessation Before Lung Cancer Diagnosis Shows Survival Benefit
https://www.onclive.com/conference-coverage/asco-2020/regardless-of-timing-smoking-cessation-before-lung-cancer-diagnosis-shows-survival-benefit

May 12th, 2020 - People who quit smoking at any time, even up to 2 years before a lung cancer diagnosis, have increased chances of survival after their diagnosis, according to data during a 2020 ASCO Virtual Scientific Program press briefing.

Videoconference intervention eases anxiety, distress among distance caregivers of patients with cancer
https://www.healio.com/hematology-oncology/practice-management/news/online/{6cf25568-b726-4935-8d86-a461eaeb44c7}/videoconference-intervention-eases-anxiety-distress-among-distance-caregivers-of-patients-with-cancer

May 12th, 2020 - Distance caregivers of patients with cancer reported significant reductions in anxiety and distress after completing a series of coaching sessions via videoconference, according to study results scheduled for presentation during the ASCO20 Virtual Scientific Program.

Video Conference Visits Effective in Reducing Stress, Anxiety in Caregivers for Patients with Cancer
https://www.onclive.com/conference-coverage/asco-2020/video-conference-visits-effective-in-reducing-stress-anxiety-in-caregivers-for-patients-with-cancer

May 12th, 2020 - The use of video conference technology significantly reduced anxiety and stress among individuals who provide care for an individual with cancer and live more than one hour away from the patient, according to data from a randomized controlled trial presented during a 2020 ASCO Virtual Scientific Program press briefing.

Integrated Geriatric Assessment Optimizes Care for Older Adults with Cancer
https://www.onclive.com/conference-coverage/asco-2020/integrated-geriatric-assessment-optimizes-care-for-older-adults-with-cancer

May 12th, 2020 - Integration of a comprehensive geriatric assessment with geriatrician-led management care improved health-related quality of life (HRQOL), unplanned hospital admissions, and treatment discontinuation among older adults undergoing systemic therapy for their cancer, according to results from the INTEGERATE study presented during a 2020 ASCO Virtual Scientific Program press briefing.